IQVIA vs Medidata (2026)
Both are incumbents in clinical research, with AI arriving on top of very large existing businesses. IQVIA sells research services, health data and technology together, and IQVIA.ai, launched in March 2026 with NVIDIA, adds a catalog of agents across clinical, commercial and real world work, built on its own data and its Med-R1 medical reasoning model. In September 2026 it promoted Predictive Clinical Development for site selection, study design, start up and data cleaning. Medidata sells the platform a trial runs on, anchored by Rave data capture. Its AI, packaged as Medidata Plus since July 2026, covers study build, data review, safety signal detection and a Dot assistant, and the company publishes its certification documents on a public trust page. IQVIA is the choice when services and data come with the purchase; Medidata when a study team wants AI inside the system it already works in.
- Agents across clinical, commercial and real world work, built on IQVIA's own data and models.
- Predictive Clinical Development for site selection, study design and start up.
- Services and data sold alongside the technology.
- AI inside Rave, from study build to data review and safety signals.
- Health Record Connect, reading patient record data into Rave forms for sites to confirm.
- ISO 27001, 27017, 27018 and 27701 documents on a public trust page.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. IQVIA and Medidata are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | IQVIA | Medidata |
|---|---|---|
| Primary category | Clinical Trials AI | Clinical Trials AI |
| Headquarters | Research Triangle Park, North Carolina | New York, New York |
| Website | iqvia.com | medidata.com |
Side by Side
Select any grade to read the note behind it.
Product updates
The latest logged changes from each vendor, newest first, each linked to its source.
IQVIA
-
Model / architecture
IQVIA launched IQVIA Life Science Models, a suite of purpose built AI models on NVIDIA Nemotron and AWS infrastructure.
Source -
Product / capability
IQVIA launched Predictive Clinical Development, a suite covering site selection and study design, an automated start up path it calls Push Button Start-Up, and real time data cleaning aimed at shortening the gap to database lock.
Source
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
IQVIA, based in Research Triangle Park, North Carolina, sells clinical research services, health data and technology to life sciences companies. IQVIA.ai, launched in March 2026 with NVIDIA, is a platform and catalog of AI agents spanning clinical, commercial and real world work: literature review, the Med-R1 Deep Research Agent built on the company's own Med-R1 8B medical reasoning model, a field force agent, commercial planning, cohort building, market insight and master data agents, and connectors into IQVIA data and customer systems.
Source: AI Health Index, September 2026
Medidata, a Dassault Systemes brand based in New York, sells clinical trial software to drug and device sponsors and contract research organizations. The platform is anchored by Rave electronic data capture and spans study build, trial management, patient experience, imaging and data review, with about 2,300 customers.
Source: AI Health Index, September 2026
Questions buyers ask
How do IQVIA and Medidata work with the EHR?
IQVIA.ai lists MCP connectors to the company's own sources (MIDAS, ChannelDynamics and other market data, real world cohorts, a scientific content index, clinical code lists) and to customer systems described only by category: trial master file systems and practitioner and organization data.
Clinical Data Studio brings in non-Medidata sources, including third party laboratories and other data capture systems. Data flows one way, from the record into the trial; no named record system, marketplace listing or integration documentation shows a production connection to a specific EHR, and the exchanges are not named. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
How are IQVIA and Medidata priced and sold?
In IQVIA's case, enterprise agreements with life sciences organizations usually sit inside existing data, services and clinical research relationships. IQVIA.ai presents a catalog with each agent's availability (now, next quarter or launch-ready) and says some capabilities deploy in IQVIA's or the client's technology stack.
For Medidata, enterprise agreements with sponsors, contract research organizations and medtech companies are scoped by study count and module. Medidata Plus, launched in July 2026, packages the AI capabilities as one layer the company describes as a predictable investment rather than per-tool costs. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
How do IQVIA and Medidata handle patient data?
With IQVIA, the company says it uses privacy enhancing technologies and anonymization at scale, and its 2025 agent release names NVIDIA NeMo Guardrails to safeguard deployment.
In Medidata's case, the trust and transparency page says the company does not use data for secondary purposes without the customer's explicit written permission, reviews every internal data use request, and runs a Data Collaboration Program in which aggregated, anonymized data sits in a separate environment. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
Which settings and specialties do IQVIA and Medidata cover?
IQVIA.ai spans clinical, commercial and real world work, and its catalog marks what is available now (literature review, deep research, field force, market insight, several connectors) against what is launch-ready or due later (commercial planning, cohort and master data agents).
The platform serves biopharmaceutical and medtech sponsors and contract research organizations across study design, build, execution and closeout, with therapeutic area solutions in oncology, vaccines and CNS; Health Record Connect also feeds Medidata Surgical Planning and real world data work that reaches beyond trials. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers.
Both records were reviewed on this site in September 2026. Neither company publishes a price.
Ask both what their models were trained on, and whether a sponsor's own study data is ever used for training.